Sesen Bio Inc expected to post a loss of 11 cents a share - Earnings Preview

Carisma Therapeutics

24/02/2023 19:34

* Sesen Bio Inc  SESN.OQ   SESN.O  is expected to show a
fall in
quarterly revenue when it reports  results on February 27
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Sesen Bio Inc is
for a
loss of 11 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sesen Bio
Inc is
$0.6​, above​ its last closing price of $0.59. ​​​

This summary was machine generated February 24 at 19:34 GMT. 
All figures in US dollars  unless otherwise stated